Po, Michael L.
HRN: 24-37-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
CEFTRIAXONE 1G (VIAL)
01/05/2024
01/12/2024
IV
2 Grams
OD
Infected Neck Mass
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes